140 related articles for article (PubMed ID: 17502731)
1. When to switch for antiretroviral treatment failure in resource-limited settings?
Vekemans M; John L; Colebunders R
AIDS; 2007 May; 21(9):1205-6. PubMed ID: 17502731
[No Abstract] [Full Text] [Related]
2. Management of antiretroviral failure and resistance in developing countries.
Hawkins C; Murphy RL
Curr Opin HIV AIDS; 2009 Nov; 4(6):538-44. PubMed ID: 20048723
[TBL] [Abstract][Full Text] [Related]
3. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
[TBL] [Abstract][Full Text] [Related]
4. Prioritizing antiretrovirals for second-line therapy in resource-limited countries.
Naidoo K
AIDS Clin Care; 2008 May; 20(5):43. PubMed ID: 19230296
[No Abstract] [Full Text] [Related]
5. COMMENTARY: understanding the benefits of pediatric anti-retroviral treatment in resource-limited settings.
Hetherington S
Pediatr Infect Dis J; 2009 Jan; 28(1):41-2. PubMed ID: 19057455
[TBL] [Abstract][Full Text] [Related]
6. Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense.
Kitkungvan D; Apisarnthanarak A; Laowansiri P; Mundy LM
HIV Med; 2008 Oct; 9(8):636-41. PubMed ID: 18643857
[TBL] [Abstract][Full Text] [Related]
7. HIV drug resistance.
Calmy A; Pascual F; Ford N
N Engl J Med; 2004 Jun; 350(26):2720-1. PubMed ID: 15215494
[No Abstract] [Full Text] [Related]
8. Choice of an initial antiretroviral regimen in the resource-limited setting: the cost of virologic failure.
Campbell TB
Clin Infect Dis; 2008 Sep; 47(5):723-5. PubMed ID: 18662135
[No Abstract] [Full Text] [Related]
9. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
Krogstad PA
J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
[No Abstract] [Full Text] [Related]
10. Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.
Hastings IM; Lalloo DG; Khoo SH
AIDS; 2007 Jan; 21(2):258-9; author reply 259-60. PubMed ID: 17197825
[No Abstract] [Full Text] [Related]
11. Darunavir: after multiple antiretroviral treatment failure: another option.
Prescrire Int; 2008 Jun; 17(95):109. PubMed ID: 18629967
[TBL] [Abstract][Full Text] [Related]
12. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
[No Abstract] [Full Text] [Related]
13. The marriage of science and optimized HIV care in resource-limited settings.
Calmy A; Pizzocolo C; Pizarro L; Brücker G; Murphy R; Katlama C;
AIDS; 2008 Nov; 22(17):2227-30. PubMed ID: 18981761
[No Abstract] [Full Text] [Related]
14. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy in resource-poor settings: scaling up inequalities?
Egger M; Boulle A; Schechter M; Miotti P
Int J Epidemiol; 2005 Jun; 34(3):509-12. PubMed ID: 15941732
[No Abstract] [Full Text] [Related]
16. World Bank meeting concludes drug resistance should not prevent distribution of antiretroviral therapy to poor countries.
Kuritzkes D; Lange J; Zewdie D
Nat Med; 2003 Nov; 9(11):1343-4. PubMed ID: 14595419
[No Abstract] [Full Text] [Related]
17. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
;
Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
[No Abstract] [Full Text] [Related]
18. Drug-resistance surveillance among newly HIV-1 diagnosed individuals in Buenos Aires, Argentina.
Dilernia DA; Lourtau L; Gomez AM; Ebenrstejin J; Toibaro JJ; Bautista CT; Marone R; Carobene M; Pampuro S; Gomez-Carrillo M; Losso MH; Salomón H
AIDS; 2007 Jun; 21(10):1355-60. PubMed ID: 17545713
[TBL] [Abstract][Full Text] [Related]
19. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan.
Chang SY; Chen MY; Lee CN; Sun HY; Ko W; Chang SF; Chang KL; Hsieh SM; Sheng WH; Liu WC; Wu CH; Kao CL; Hung CC; Chang SC
J Antimicrob Chemother; 2008 Mar; 61(3):689-93. PubMed ID: 18227088
[TBL] [Abstract][Full Text] [Related]
20. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.
Bishai D; Colchero A; Durack DT
AIDS; 2007 Jun; 21(10):1333-40. PubMed ID: 17545710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
